These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 1682020)
1. Multidrug resistance: a novel class of membrane-associated transport proteins is identified. Gros P; Shustik C Cancer Invest; 1991; 9(5):563-9. PubMed ID: 1682020 [No Abstract] [Full Text] [Related]
2. Multidrug resistance in human cancer. Goldstein LJ; Pastan I; Gottesman MM Crit Rev Oncol Hematol; 1992; 12(3):243-53. PubMed ID: 1353966 [No Abstract] [Full Text] [Related]
3. Multidrug resistance: molecular biology and clinical relevance. Rothenberg M; Ling V J Natl Cancer Inst; 1989 Jun; 81(12):907-10. PubMed ID: 2567355 [No Abstract] [Full Text] [Related]
4. Drug resistance and cancer. Morrow CS; Cowan K Adv Exp Med Biol; 1993; 330():287-305. PubMed ID: 8103619 [No Abstract] [Full Text] [Related]
5. Multidrug resistance in leukemia. Rischin D; Ling V Cancer Treat Res; 1993; 64():269-93. PubMed ID: 8095795 [No Abstract] [Full Text] [Related]
6. Multidrug resistance: P-glycoprotein and its allies--the elusive foes. Chabner BA; Fojo A J Natl Cancer Inst; 1989 Jun; 81(12):910-3. PubMed ID: 2567356 [No Abstract] [Full Text] [Related]
8. Current status and future directions of research on multidrug resistance. The impact of contemporary biotechnology. Mickisch GH Urol Res; 1993 Mar; 21(2):79-81. PubMed ID: 8099243 [No Abstract] [Full Text] [Related]
9. Multidrug resistance due to P-glycoprotein. Burt RK; Fojo AT; Thorgeirsson SS Hosp Pract (Off Ed); 1990 Apr; 25(4):67-72, 74, 77. PubMed ID: 1969865 [TBL] [Abstract][Full Text] [Related]
12. Genetic aspects of multidrug resistance. Pauly M; Ries F; Dicato M Med Oncol Tumor Pharmacother; 1992; 9(1):21-4. PubMed ID: 1364127 [TBL] [Abstract][Full Text] [Related]
13. Multidrug resistance: clinical findings and implications. Friedlander ML; Bell DR Cancer Treat Res; 1989; 42():63-77. PubMed ID: 2577108 [No Abstract] [Full Text] [Related]
14. Failure to detect the P-glycoprotein multidrug resistant phenotype in cases of resistant childhood acute lymphocytic leukaemia. Ubezio P; Limonta M; D'Incalci M; Damia G; Masera G; Giudici G; Wolverton JS; Beck WT Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1895-9. PubMed ID: 2576650 [No Abstract] [Full Text] [Related]
15. The role of P-glycoprotein in drug-resistant hematologic malignancies. Dalton WS; Grogan TM; Miller TP Cancer Treat Res; 1991; 57():187-208. PubMed ID: 1686717 [No Abstract] [Full Text] [Related]
16. Expression of the MDR1 gene in human cancers. Goldstein LJ; Gottesman MM; Pastan I Cancer Treat Res; 1991; 57():101-19. PubMed ID: 1686712 [No Abstract] [Full Text] [Related]
17. Is the multidrug transporter a flippase? Higgins CF; Gottesman MM Trends Biochem Sci; 1992 Jan; 17(1):18-21. PubMed ID: 1374941 [TBL] [Abstract][Full Text] [Related]
18. Mdr 2 knockout mice link biliary phospholipid deficiency with small bile duct destruction. Leveille-Webster CR; Arias IM Hepatology; 1994 Jun; 19(6):1528-31. PubMed ID: 7910576 [No Abstract] [Full Text] [Related]
19. Charles F. Kettering Prize. P-glycoprotein and resistance to anticancer drugs. Ling V Cancer; 1992 May; 69(10):2603-9. PubMed ID: 1348966 [No Abstract] [Full Text] [Related]
20. Multidrug resistance genes, p-glycoprotein and the liver. Arias IM Hepatology; 1990 Jul; 12(1):159-65. PubMed ID: 1973680 [No Abstract] [Full Text] [Related] [Next] [New Search]